Aerie Pharmaceuticals, Inc. Names Marvin J. Garrett As Vice President, Regulatory Affairs And Quality Assurance
Published: Feb 25, 2014
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class glaucoma therapies, today announced that Marvin J. Garrett has been named Vice President, Regulatory Affairs and Quality Assurance of the Company.
Help employers find you! Check out all the jobs and post your resume.